Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
U.S. FDA Grants Emergency Use AuthorizationSolution Leverages Existing Equipment to Allow Hospitals to Decontaminate On-site DUBLIN, IRELAND, April 10, 2020 (GLOBE NEWSWIRE) -- STERIS plc...
-
DUBLIN, IRELAND, Feb. 19, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Raymond James Institutional Investor Conference on...
-
Third quarter revenue grows 11% as reported, 12% constant currency organicEPS as reported increases to $1.23, adjusted EPS increases to $1.45Outlook updated to reflect stronger than anticipated...
-
DUBLIN, IRELAND, Jan. 27, 2020 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 third quarter...
-
Second quarter revenue grows 9% as reported, 10% constant currency organic;EPS as reported increases to $1.11, adjusted EPS increases to $1.32; Outlook updated to reflect stronger than anticipated...
-
DUBLIN, IRELAND, Oct. 22, 2019 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 second quarter...
-
Dublin, Ireland, Aug. 26, 2019 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Global Healthcare Conference on...
-
Dublin, Ireland, Aug. 05, 2019 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2020 first quarter ended June 30, 2019. ...
-
Dublin, Ireland, July 23, 2019 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 first quarter...
-
Strong fourth quarter revenue growthFourth quarter earnings improve to $1.27 per diluted share as reported; adjusted earnings per diluted share increase to $1.53Full year fiscal 2019 revenue growth...